BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4638878)

  • 1. [New drug for the treatment of depressive syndromes].
    Fiume S
    Clin Ter; 1972 Aug; 62(4):367-76. PubMed ID: 4638878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in the use of a new thymoleptic (34,276-Ba) in the treatment of depressive states].
    Lobova LK; Romel' TE; Igonin AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):925-9. PubMed ID: 5050053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with melitracen in the treatment of depressive states].
    Brasseur R
    Schweiz Rundsch Med Prax; 1971 Feb; 60(8):249-53. PubMed ID: 5553886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of treatment with Melitracen (trausabun) in depressive states].
    Wojdyslawska I
    Psychiatr Pol; 1970; 4(4):449-53. PubMed ID: 5472582
    [No Abstract]   [Full Text] [Related]  

  • 5. EEG changes in treatment with maprotiline.
    Misurec J; Náhunek K; Rodová A
    Act Nerv Super (Praha); 1973 May; 15(2):110. PubMed ID: 4752637
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with maprotyline in endogenous depression.
    Náhunek K; Kamenická V; Rodová A; Svestka J; Misurec J
    Act Nerv Super (Praha); 1973 May; 15(2):108-10. PubMed ID: 4752636
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new antidepressive agent: C 34,276-Ba or maprotyline, 1st tetracyclic thymoanaleptic. Clinical study].
    Nieto Gómez D; Pérez Rincón H
    Prensa Med Mex; 1973; 38(11):429-34. PubMed ID: 4603181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with the new antidepressive agent Maprotilin 34'276 Ba].
    Floru L
    Med Welt; 1973 Aug; 24(33):1283-6. PubMed ID: 4764444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychopharmacological study with butryptiline hydrochloride in patients with different depressive disorders].
    Saldaña Hernández OH; Hernández González J
    Prensa Med Mex; 1973; 38(5):215-9. PubMed ID: 4782090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of dibencycladine (Ludiomil) and imipramine in the treatment of psychotic depression].
    Roy JY; Pinard G; Hillel J; Gagnon MA; Tétreault L
    Int J Clin Pharmacol; 1973 Feb; 7(1):54-61. PubMed ID: 4699385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the clinical testing of amitriptylin and C 34,276-Ba (dibenzobicyclooctadiene derivative) in a double-blind study].
    Bruck J; Söllner E; Tschabitscher H
    Nervenarzt; 1974 Sep; 45(9):492-6. PubMed ID: 4612394
    [No Abstract]   [Full Text] [Related]  

  • 12. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A
    S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with the new psychoactivator Deanxit (Melitracen and Flupenthixol)].
    Cermak I; Ringel R
    Schweiz Rundsch Med Prax; 1971 Jun; 60(23):757-62. PubMed ID: 5104765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results with the use of melitracen in depressive syndromes].
    Di Genio R; Marzo M
    Clin Ter; 1976 Apr; 77(2):171-81. PubMed ID: 795587
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of N 7001 (Metrisil) and imipramine on a series of depressive patients.
    Thorell LH; Wretmark G
    Acta Psychiatr Scand; 1974; 50(5):508-15. PubMed ID: 4618028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Melitracene as an antidepressive agent].
    Ambrozi L; Birkmayer W
    Arzneimittelforschung; 1967 Oct; 17(10):1329-31. PubMed ID: 5632889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems of differentiated thymoleptic therapy in phasic depressions].
    Smulevich AB; Vorob'ev VIu; Zavidovskaia GI; Lobova EK; Balashova MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):912-8. PubMed ID: 4454918
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of melitracen and imipramine in treatment of depressed patients.
    Biros D; Schiele BC; Ferguson D
    Curr Ther Res Clin Exp; 1969 May; 11(5):289-95. PubMed ID: 4977401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of melitracen and placebo in depression using sequential analysis].
    Kawakita TM; Suzuki T; Ikawa G
    Nihon Rinsho; 1967 Oct; 25(8):1689-96. PubMed ID: 4870439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.